DK0513351T3 - 2-Nitroimidazolderivat, fremstilling deraf og strålingssensibilisator indeholdende samme som aktiv bestanddel - Google Patents
2-Nitroimidazolderivat, fremstilling deraf og strålingssensibilisator indeholdende samme som aktiv bestanddelInfo
- Publication number
- DK0513351T3 DK0513351T3 DK91902775.5T DK91902775T DK0513351T3 DK 0513351 T3 DK0513351 T3 DK 0513351T3 DK 91902775 T DK91902775 T DK 91902775T DK 0513351 T3 DK0513351 T3 DK 0513351T3
- Authority
- DK
- Denmark
- Prior art keywords
- active ingredient
- preparation
- containing same
- nitroimidazole derivative
- radiation sensitizer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016721A JP2626727B2 (ja) | 1990-01-26 | 1990-01-26 | 2―ニトロイミダゾール誘導体、その製造法及びこれを有効成分とする放射線増感剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0513351T3 true DK0513351T3 (da) | 1996-11-25 |
Family
ID=11924130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91902775.5T DK0513351T3 (da) | 1990-01-26 | 1991-01-24 | 2-Nitroimidazolderivat, fremstilling deraf og strålingssensibilisator indeholdende samme som aktiv bestanddel |
Country Status (10)
Country | Link |
---|---|
US (1) | US5270330A (es) |
EP (1) | EP0513351B1 (es) |
JP (1) | JP2626727B2 (es) |
KR (2) | KR927003539A (es) |
AT (1) | ATE143950T1 (es) |
CA (1) | CA2074533C (es) |
DE (1) | DE69122605T2 (es) |
DK (1) | DK0513351T3 (es) |
ES (1) | ES2094218T3 (es) |
WO (1) | WO1991011440A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994014778A1 (en) * | 1992-12-18 | 1994-07-07 | Pola Chemical Industries, Inc. | Optically active 2-nitroimidazole derivative, process for producing the same, and intermediate for producing the same |
US5700825A (en) * | 1995-03-31 | 1997-12-23 | Florida State University | Radiosensitizing diamines and their pharmaceutical preparations |
US6060604A (en) * | 1995-03-31 | 2000-05-09 | Florida State University | Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
US6331286B1 (en) | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
US5929104A (en) * | 1997-04-02 | 1999-07-27 | Pola Chemical Industries, Inc. | Method for inducing apoptosis of cancer cell |
US8974363B2 (en) | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
US8557298B2 (en) | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
US20020001567A1 (en) * | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
US8470296B2 (en) * | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
US7384623B1 (en) | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
EP1590440A4 (en) * | 2003-02-03 | 2009-03-18 | Palo Alto Inst Of Molecular Me | CELL-KILLING MOLECULES AND METHODS FOR THEIR USE |
ZA200507752B (en) * | 2003-03-28 | 2007-01-31 | Threshold Pharmaceuticals Inc | Compositions and methods for treating cancer |
WO2005086951A2 (en) * | 2004-03-10 | 2005-09-22 | Threshold Pharmaceuticals, Inc. | Hypoxia-activated anti-cancer agents |
KR100832167B1 (ko) * | 2004-06-24 | 2008-05-23 | 토요 수이산 가부시키가이샤 | 방사선치료 증감제 |
WO2006078903A1 (en) * | 2005-01-21 | 2006-07-27 | Matthews Richard H | Radiosensitizer formulations comprising nitrohistidine derivatives |
WO2007002931A2 (en) | 2005-06-29 | 2007-01-04 | Threshold Pharmaceuticals, Inc. | Phosphoramidate alkylator prodrugs |
WO2008083101A1 (en) * | 2006-12-26 | 2008-07-10 | Threshold Pharmaceuticals, Inc. | Phosphoramidate alkylator prodrugs for the treatment of cancer |
EP2128140B1 (en) | 2007-01-23 | 2012-03-14 | Pola Pharma Inc. | Method for producing 2-nitroimidazole derivative |
DK2116241T3 (en) | 2007-01-26 | 2016-06-06 | Pola Pharma Inc | pharmaceutical composition |
WO2008152764A1 (ja) | 2007-06-14 | 2008-12-18 | Pola Pharma Inc. | 医薬組成物 |
US20090118031A1 (en) * | 2007-11-01 | 2009-05-07 | Qualizza Gregory K | Shaft Structure with Configurable Bending Profile |
JP6082644B2 (ja) * | 2013-03-22 | 2017-02-15 | 株式会社ポーラファルマ | ドラニダゾール構成光学異性体の製造方法 |
JP6071715B2 (ja) * | 2013-03-22 | 2017-02-01 | 株式会社ポーラファルマ | ドラニダゾール構成光学異性体の製造方法 |
JP7353606B2 (ja) | 2017-10-02 | 2023-10-02 | 慶應義塾 | 癌幹細胞インヒビター |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4462992A (en) * | 1982-02-08 | 1984-07-31 | Research Corporation | Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof |
JPS59139363A (ja) * | 1983-01-31 | 1984-08-10 | Kayaku:Kk | 2−ニトロイミダゾ−ル誘導体およびその製造法 |
JPS6075430A (ja) * | 1983-08-31 | 1985-04-27 | Kayaku:Kk | 放射線増感剤 |
JPH0819111B2 (ja) * | 1987-10-22 | 1996-02-28 | ポーラ化成工業株式会社 | 2―ニトロイミダゾール誘導体及びこれを有効成分とする放射線増感剤 |
JP3291590B2 (ja) * | 1992-08-26 | 2002-06-10 | キヤノン株式会社 | カラートナー、カラー現像剤及び画像形成方法 |
-
1990
- 1990-01-26 KR KR1019920701754A patent/KR927003539A/ko not_active IP Right Cessation
- 1990-01-26 JP JP2016721A patent/JP2626727B2/ja not_active Expired - Lifetime
-
1991
- 1991-01-24 ES ES91902775T patent/ES2094218T3/es not_active Expired - Lifetime
- 1991-01-24 DE DE69122605T patent/DE69122605T2/de not_active Expired - Lifetime
- 1991-01-24 WO PCT/JP1991/000074 patent/WO1991011440A1/ja active IP Right Grant
- 1991-01-24 AT AT91902775T patent/ATE143950T1/de not_active IP Right Cessation
- 1991-01-24 CA CA002074533A patent/CA2074533C/en not_active Expired - Lifetime
- 1991-01-24 US US07/915,814 patent/US5270330A/en not_active Expired - Lifetime
- 1991-01-24 EP EP91902775A patent/EP0513351B1/en not_active Expired - Lifetime
- 1991-01-24 DK DK91902775.5T patent/DK0513351T3/da active
-
1992
- 1992-07-24 KR KR92701724A patent/KR0145333B1/ko active
Also Published As
Publication number | Publication date |
---|---|
DE69122605T2 (de) | 1997-02-13 |
ATE143950T1 (de) | 1996-10-15 |
JPH03223258A (ja) | 1991-10-02 |
ES2094218T3 (es) | 1997-01-16 |
US5270330A (en) | 1993-12-14 |
CA2074533C (en) | 2000-10-17 |
KR0145333B1 (en) | 1998-07-15 |
JP2626727B2 (ja) | 1997-07-02 |
DE69122605D1 (de) | 1996-11-14 |
EP0513351A1 (en) | 1992-11-19 |
WO1991011440A1 (fr) | 1991-08-08 |
KR927003539A (ko) | 1992-12-18 |
EP0513351B1 (en) | 1996-10-09 |
EP0513351A4 (en) | 1993-11-10 |
CA2074533A1 (en) | 1991-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0513351T3 (da) | 2-Nitroimidazolderivat, fremstilling deraf og strålingssensibilisator indeholdende samme som aktiv bestanddel | |
DK0471236T3 (da) | Imidazopyridinderivater og deres anvendelse | |
ATE104971T1 (de) | 2-aminopyrimidinon-derivate. | |
NO180679C (no) | Pyranylcyanoguanidin-derivater, preparater som inneholder dem og anvendelse derav | |
ES2167463T3 (es) | Componentes de un compuesto medicinal que comprenden derivados n-sustituidos de la o-toluidina y preparacion percutaneamente absorbible. | |
HU206701B (en) | Process for producing substituted flavonoid derivatives and salts and pharmaceutical compositions containing these compounds | |
NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
MY103241A (en) | Imidazole and 1,2,4 triazole derivatives | |
MX9100607A (es) | Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene | |
ATE18218T1 (de) | Antifungische triazolyl-propanol-derivate. | |
MX9206157A (es) | Derivados de imidazol y composiciones farmaceuticas que contienen a los mismos. | |
NO961236L (no) | Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater | |
TR199800813T2 (xx) | Nitrik oksit sintaz�n�n �nleyicileri olarak amidin, isot�re t�revleri. | |
IL89324A0 (en) | Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives | |
NO922151L (no) | Gingerol og gingerdiolderivater som hypokolesterolemiske og antiatherosklerotiske midler | |
ATE184605T1 (de) | Methotrexat-derivate | |
ZA877454B (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
NO179755C (no) | Fremgangsmåte for fremstilling av deoksymulundocandin | |
NO832723L (no) | Fremgangsmaate for oksydasjon av vinylbenzenforbindelser | |
NO923983D0 (no) | Bisfenyletanderivater, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse | |
ATE254131T1 (de) | Benzimidazolderivate | |
PL297368A1 (en) | Novel derivatives of 2h-benzo (b) pyrane substituted with aryl or n-heteroaryl at position 4, method of obtaining them and their applications as well as preparation containing these compounds | |
FI854985A (fi) | Foerfarande foer framstaellning av farmaceutiskt aktiva n-substituerade aziridin-2-karboxylsyraderivat. | |
NO932002L (no) | Nye tiosemikarbazonsyreestere | |
ES8207542A1 (es) | Un procedimiento para la preparacion de 1rs,4rs,5rs-4-(4,8 dimetil-5-hidroxi-7-nomen-1-1-il)-4-metil-3,8-dioxabiciclo(3.2.1)octano-1.aletico. |